241
UroX Biomarker Bladder Cancer Study
Condition(s):Bladder CancerLast Updated:June 4, 2019Recruiting
Cancer: 89575 Clinical Trials, Page 25 of 8958
Hide Studies Not Open or Pending
242
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Condition(s):Breast CancerLast Updated:November 14, 2017Terminated
243
Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer
Condition(s):Prostate CancerLast Updated:February 5, 2020Recruiting
244
RObotic Versus LAparoscopic Resection for Rectal Cancer
Condition(s):Rectal CancerLast Updated:December 2, 2015Unknown status
245
COPDGene/Lung Cancer Center Database
Condition(s):Lung Cancer; COPDLast Updated:February 27, 2020Enrolling by invitation
246
Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer
Condition(s):Breast CancerLast Updated:August 14, 2020Recruiting
247
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
Condition(s):Prostate Cancer; Prosatatic NeoplasmLast Updated:October 19, 2020Recruiting
248
Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Condition(s):Lung CancerLast Updated:May 21, 2013Completed
249
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Condition(s):Pancreatic Cancer; Metastatic Breast Cancer; Metastatic Lung Cancer; Metastatic Colon Cancer; Metastatic Melanoma; Metastatic Prostate CancerLast Updated:July 20, 2018Terminated
250
Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients
Condition(s):Breast Cancer; Lung CancerLast Updated:July 2, 2015Completed